Innovating with
Extracellular vesicles
Leading the future of biotechnology through hiPSC-derived extracellular vesicles, advanced diagnostics, and scalable bioprocessing solutions.
Our Core Technologies
Pioneering the next generation of extracellular vesicles-based therapeutics through innovative hiPSC technologies
hiPSC
Derived EVs
Revolutionary extracellular vesicles derived from human induced pluripotent stem cells for therapeutic applications.
Engineered hiPSC Derived EVs
Precisely engineered extracellular vesicles with enhanced targeting capabilities and therapeutic payload delivery systems.
Sustained Release hiPSC Derived EVs
Proprietary formulation providing controlled and sustained release of therapeutic extracellular vesicles.
.png){kind=small}
IVD Products
In Vitro Diagnostic products for infectious, metabolic, reproductive, and cancer biomarker detection.
Bioprocessing Solutions
Scalable production systems for extracellular vesicles manufacturing and quality assurance
2D Clone Systems
Traditional monolayer cell culture systems optimized for high-yield extracellular vesicles production with consistent quality metrics and reproducible results.
3D Clone Systems
Advanced three-dimensional cell culture platforms that mimic physiological conditions for enhanced extracellular vesicles production and bioactivity.
Large-Scale Production
Industrial-scale bioreactor systems with GMP compliance for commercial extracellular vesicles manufacturing and pharmaceutical-grade production.
Ready to Advance Your Research?
Partner with Genefront Inc for cutting-edge extracellular vesicles technologies and diagnostic solutions. Let's innovate together for a healthier future.